Evolving therapeutic role of bisphosphonates in multiple myeloma.
作者信息
Ural A U, Avcu F
出版信息
Br J Cancer. 2005 Jul 25;93(2):267-8; author reply 269. doi: 10.1038/sj.bjc.6602694.
Abstract
摘要
相似文献
1
Evolving therapeutic role of bisphosphonates in multiple myeloma.双膦酸盐在多发性骨髓瘤中不断演变的治疗作用。
Br J Cancer. 2005 Jul 25;93(2):267-8; author reply 269. doi: 10.1038/sj.bjc.6602694.
2
Bisphosphonates in multiple myeloma: a fractured consensus.双膦酸盐在多发性骨髓瘤中的应用：一个存在分歧的共识。
Leuk Lymphoma. 2015 Mar;56(3):553-4. doi: 10.3109/10428194.2014.964703. Epub 2014 Nov 5.
3
Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
Int J Lab Hematol. 2007 Oct;29(5):395-7. doi: 10.1111/j.1365-2257.2006.00860.x.
4
Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma.
Br J Haematol. 2010 Dec;151(5):530-1. doi: 10.1111/j.1365-2141.2010.08388.x. Epub 2010 Sep 29.
5
Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma.甲羟戊酸途径抑制剂作为多发性骨髓瘤的潜在治疗药物。
Leuk Res. 2007 Mar;31(3):341-52. doi: 10.1016/j.leukres.2006.07.018. Epub 2006 Sep 22.
6
Bisphosphonates for Patients Diagnosed With Multiple Myeloma.双磷酸盐类药物用于多发性骨髓瘤患者。
JAMA. 2018 Oct 9;320(14):1483-1484. doi: 10.1001/jama.2018.13773.
7
Osteonecrosis of the jaw and bisphosphonates.颌骨骨坏死与双膦酸盐类药物
N Engl J Med. 2005 Jul 7;353(1):99-102; discussion 99-102. doi: 10.1056/NEJM200507073530120.
8
Osteonecrosis of the jaw and bisphosphonates.颌骨骨坏死与双膦酸盐
N Engl J Med. 2005 Jul 7;353(1):99-102; discussion 99-102.
9
Further analyses of the Myeloma IX Study.骨髓瘤IX研究的进一步分析。
Lancet. 2011 Aug 27;378(9793):768-9. doi: 10.1016/S0140-6736(11)61374-3.
10
Zoledronic acid for all patients with newly diagnosed multiple myeloma?唑来膦酸用于所有新诊断的多发性骨髓瘤患者？
Lancet Oncol. 2011 Aug;12(8):711-2. doi: 10.1016/S1470-2045(11)70178-4. Epub 2011 Jul 21.
引用本文的文献
1
Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibody.一种 PTHrP 阻断单克隆抗体增强紫杉醇、阿霉素和唑来膦酸对三阴性乳腺癌细胞的增殖抑制作用。
Am J Cancer Res. 2013 Nov 1;3(5):500-8. eCollection 2013.
2
Bisphosphonate treatment and radiotherapy in metastatic breast cancer.
Med Oncol. 2008;25(3):350-5. doi: 10.1007/s12032-008-9044-4. Epub 2008 Jan 17.
3
In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells.唑来膦酸与放疗对乳腺癌细胞的体外协同细胞减灭作用。
Breast Cancer Res. 2006;8(4):R52. doi: 10.1186/bcr1543.
本文引用的文献
1
The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.双膦酸盐唑来膦酸可抑制通过腹腔注射 pristane 在 BALB/c 小鼠中诱导产生的浆细胞瘤的发展。
Eur J Haematol. 2005 Jun;74(6):496-500. doi: 10.1111/j.1600-0609.2005.00427.x.
2
Evolving treatment strategies for myeloma.骨髓瘤不断演进的治疗策略
Br J Cancer. 2005 Jan 31;92(2):217-21. doi: 10.1038/sj.bjc.6602341.
3
The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.双膦酸盐唑来膦酸在人骨髓瘤细胞系中诱导细胞毒性，同时具有地塞米松和沙利度胺的增强作用。
Int J Hematol. 2003 Dec;78(5):443-9. doi: 10.1007/BF02983818.
4
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.唑来膦酸治疗携带5T2MM的小鼠可抑制骨髓瘤骨病的发展：有证据表明骨溶解、肿瘤负荷和血管生成减少，生存期延长。
J Bone Miner Res. 2003 Mar;18(3):482-92. doi: 10.1359/jbmr.2003.18.3.482.
5
Antitumor effects of bisphosphonates.双膦酸盐的抗肿瘤作用。
Cancer. 2003 Feb 1;97(3 Suppl):840-7. doi: 10.1002/cncr.11128.
6
Bisphosphonate therapy in multiple myeloma: past, present, future.多发性骨髓瘤中的双膦酸盐治疗：过去、现在与未来。
Eur J Haematol. 2002 Nov-Dec;69(5-6):257-64. doi: 10.1034/j.1600-0609.2002.02796.x.
7
8
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines.
Leukemia. 2000 May;14(5):841-4. doi: 10.1038/sj.leu.2401770.
9
Anti-myeloma activity of pamidronate in vivo.帕米膦酸二钠在体内的抗骨髓瘤活性。
Br J Haematol. 1998 Nov;103(2):530-2. doi: 10.1046/j.1365-2141.1998.00976.x.
10
Bisphosphonates as anticancer drugs.双膦酸盐类作为抗癌药物。
N Engl J Med. 1998 Aug 6;339(6):398-400. doi: 10.1056/NEJM199808063390609.
Zotero 插件